Drug that modifies gene activity could help some older leukaemia patients

Older patients with acute myeloid leukaemia (AML) might benefit from a drug that reactivates genes that cancer cells turn off, according to research at Washington University School of Medicine in St. Louis and collaborating institutions. The researchers say the findings support further investigation of the drug, decitabine, as a first-line treatment for these patients, who have limited treatment options...

Read the whole article on

More from